Top Researchers
Top Medicine Researchers at The Ohio State University for 2026
The Ohio State University’s recent Medicine research spans clinical care, translational science, and population health. Looking across the last year of work, a clear pattern emerges: investigators are studying how to improve outcomes, refine therapies, and better understand the systems that shape patient health.
Below, you’ll find a snapshot of researchers whose recent publications reflect that breadth, from oncology and hematology to epidemiology, surgery, and imaging. Together, their work shows how active the university community has been across both bedside questions and larger health trends.
Featured Researchers
Electra D. Paskett
Electra D. Paskett’s recent work at The Ohio State University centers on oncology and the economics of cancer care, with studies on financial toxicity, survivorship information-seeking, and weight-loss intervention outcomes in breast cancer.
Activity over the last year: 40 indexed journal articles.
Top publications:
- Impact of age and treatment-related adverse events on financial toxicity among patients with breast cancer: a systematic review (Aug 2025)
- Digital information-seeking behaviors among cancer survivors: associations with sociodemographic determinants, cancer history, and perceived health (Nov 2025)
- Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer (Aug 2025)
Ashish Manne
Ashish Manne focuses on oncology, cancer research, and hepatology, with recent publications on immune checkpoint inhibitors for hepatocellular carcinoma, adoptive cell therapies in pancreatic cancer, and a phase I trial in metastatic colorectal cancer.
Activity over the last year: 29 indexed journal articles.
Top publications:
- Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma (Mar 2025)
- Advancing Immunotherapy in Pancreatic Cancer: A Brief Review of Emerging Adoptive Cell Therapies (Feb 2025)
- Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial (Mar 2025)
Sumithira Vasu
Sumithira Vasu’s recent publications at The Ohio State University emphasize hematology, oncology, and immunology through studies of measurable residual disease, transplant outcomes, and maintenance therapy in acute myeloid leukemia.
Activity over the last year: 39 indexed journal articles.
Top publications:
- Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD–mutated AML (Jan 2025)
- Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation (Sep 2025)
- Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia (Jul 2025)
Kartik K. Venkatesh
Kartik K. Venkatesh works across obstetrics and gynecology, infectious diseases, and epidemiology, with recent attention to rural maternal health, pregnancy-related cardiovascular risk, and neighborhood disadvantage in severe maternal morbidity.
Activity over the last year: 32 indexed journal articles.
Top publications:
- Rural maternal health interventions: A scoping review and implications for best practices (Jan 2025)
- Hypertensive disorders of pregnancy and gestational diabetes mellitus and predicted risk of maternal cardiovascular disease 10–14 years after delivery: A prospective cohort (Jan 2025)
- Neighbourhood Socioeconomic Disadvantage and Severe Maternal Morbidity: Secondary Analysis of a Prospective Cohort (Sep 2025)
Daniel M. Prevedello
Daniel M. Prevedello’s recent work spans surgery, epidemiology, and endocrinology, with papers on papillary craniopharyngioma management, endoscopic endonasal anatomy, and transorbital skull base feasibility.
Activity over the last year: 27 indexed journal articles.
Top publications:
- Papillary craniopharyngioma management in the era of BRAF and MEK inhibition (Feb 2025)
- Defining the caudal limits of the endoscopic endonasal approach to the craniovertebral junction: anatomic study correlating radiographic measures (Jan 2025)
- Endoscopic Transorbital Extended Middle Fossa Approach: A Potential Addition to the Lateral Skull Base Surgical Armamentarium–Anatomic Feasibility Study (Jun 2025)
Alice S. Mims
Alice S. Mims draws on hematology, molecular biology, and genetics in recent studies of acute myeloid leukemia, including azacitidine-venetoclax combinations, clonal architecture, and randomized treatment comparisons.
Activity over the last year: 35 indexed journal articles.
Top publications:
- Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1 -Mutated or KMT2A -Rearranged AML (Jun 2025)
- Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia (May 2025)
- Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia (Nov 2025)
Jennifer A. Woyach
Jennifer A. Woyach’s recent research in genetics and hematology examines chronic lymphocytic leukemia, including long-term treatment outcomes, resistance to targeted therapies, and consensus guidance on Richter transformation.
Activity over the last year: 28 indexed journal articles.
Top publications:
- Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN (Apr 2025)
- Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice (Jun 2025)
- International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations (Apr 2025)
Orlando P. Simonetti
Orlando P. Simonetti’s recent publications connect radiology, cardiology, and imaging physics, highlighting MRI-guided cardiac procedures, five-dimensional cardiovascular magnetic resonance, and cardiopulmonary responses to acute exogenous ketosis.
Activity over the last year: 29 indexed journal articles.
Top publications:
- Feasibility of magnetic resonance imaging-guided cardiac catheterization, angioplasty, and stenting in a commercial wide-bore 0.55T scanner (Jan 2025)
- Measuring biventricular function and left atrial volume in a single five-dimensional whole-heart cardiovascular magnetic resonance scan at 0.55T (Jan 2025)
- Cardiopulmonary responses to acute exogenous ketosis at rest, and during submaximal and maximal exercise (May 2025)
What The Ohio State University's Medicine Community Is Working On
Across the featured researchers, oncology and hematology appear most often, showing sustained attention to cancer biology, treatment response, transplant care, and targeted therapy resistance. Epidemiology and genetics also show up repeatedly, reflecting work that links clinical outcomes to population patterns and molecular mechanisms. Together, these subfields suggest a community focused on improving diagnosis, personalizing therapy, and understanding how disease and care intersect across different patient groups.- Oncology - seen across 3 of the featured researchers
- Hematology - seen across 3 of the featured researchers
- Epidemiology - seen across 2 of the featured researchers
- Genetics - seen across 2 of the featured researchers
- Economics and Econometrics - seen across 1 of the featured researchers
From cancer therapy and blood disorders to maternal health and advanced imaging, these researchers illustrate the range of medicine being pursued at The Ohio State University. Explore the names below to see how different specialties connect through shared questions about care, outcomes, and innovation. If you’re organizing your own academic workflow, Resub can also help with citation discovery, manuscript formatting, and submission preparation.
Top researchers use tools to scale their productivity and impact. Try Livewrite for free today.